---
title: "XORTX Therapeutics (XRTX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/XRTX.US/norm.md"
symbol: "XRTX.US"
name: "XORTX Therapeutics"
parent: "https://longbridge.com/en/quote/XRTX.US.md"
datetime: "2026-03-08T02:20:37.298Z"
locales:
  - [en](https://longbridge.com/en/quote/XRTX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/XRTX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/XRTX.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/XRTX.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/XRTX.US/norm.md)


# XORTX Therapeutics (XRTX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0902 | -0.1337 | -0.1900 | -0.1900 | 0.0373 |
| ROE | -116.40% | -129.76% | -120.32% | -91.96% | 17.92% |
| Revenue | - | - | - | - | - |
| Net income | -590462.00 | -649469.00 | -717700.00 | -698673.00 | 122535.00 |
| Operating income | -579088.00 | -479352.00 | -690352.00 | -791049.00 | -454522.00 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 2.68M | 2.81M | 2.74M | 3.50M | 4.09M |
| Leverage | 1.29 | 1.42 | 1.35 | 1.28 | 1.23 |
| BVPS | 0.2994 | 0.3787 | 0.5360 | 0.7236 | 0.9584 |
| Turnover | - | - | - | - | - |
| Cash & STI | 864514.00 | 1.19M | 1.06M | 1.90M | 2.47M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 37065.00 | 59602.00 | 82490.00 | 15257.00 | 34721.00 |
| Net debt | -827227.00 | -1.13M | -983004.00 | -1.88M | -2.43M |

## Cash Flow Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -701857.00 | -629617.00 | -793519.00 | -643730.00 | -886408.00 |
| Investing CF | -264257.00 | -5486.00 | -21825.00 | -3385.00 | -4036.00 |
| Financing CF | 632532.00 | 770879.00 | -43444.00 | 67577.00 | 1.11M |
| Free CF | -802768.00 | -85768.00 | -522268.00 | -445506.00 | -1.28M |
| OCF coverage | -3218.49% | -2945.03% | -3411.08% | -2783.94% | -3907.81% |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |
